News & Insights
Sort By
Insights 1 result
Insights
|March 6, 2024
Client Insight: SEC Adopts New SPAC Regulatory Regime
Extension of Traditional IPO Investor Protections to SPAC Transactions Will Significantly Increase Costs, Complexity and Potential Liability for Market Participants Throughout the SPAC Lifecycle
Events 7 Results
Events
|March 31, 2026
This session gives CFOs and GCs of late-stage private companies a practical, end-to-end IPO roadmap—from drafting the S-1 and structuring the offering to investor meetings, pricing, lockups, and the 2026 market outlook
Events
|March 17, 2026
Post-IPO: Engaging Shareholders with Confidence and Credibility
This webinar equips GCs and CFOs of public companies with strategies to navigate shareholder communications, from annual meetings to investor engagement, with insights from Gunderson Dettmer’s Alexa Belonick and Brett Pletcher
Events
|February 25, 2025
Webinar: The Nimble Dance: Dual Track Transformation via IPO or M&A
M&A and Public Offerings leaders, Andrew Luh, John Olson and Andrew Thorpe, hosted a webinar on unpacking the dual-track strategy and how company leaders can be prepared to pivot quickly between the IPO and M&A paths
Client News 4 Results
Client News
|December 19, 2025
Gunderson Dettmer Represents Client Andersen Group in its $202.4 million IPO
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP represented Andersen Group Inc. (NYSE: ANDG), a leading provider of independent tax, valuation and financial advisory services to individuals and family offices, businesses and funds in the United States, in its initial public offering of 12,650,000 shares of its Class A common stock, at a public offering price of $16 per share.
Client News
|January 17, 2025
3E Network Announces Initial Public Offering
3E Network, a business-to-business information technology business solutions provider, announces its initial public offering.
Client News
|April 5, 2024
Contineum Therapeutics Announces Initial Public Offering
Clinical stage biopharmaceutical company, Contineum Therapeutics, announces the pricing of its initial public offering of 6,875,000 shares of its Class A common stock at a price to the public of $16.00 per share.
Firm News 8 Results
Firm News
|November 20, 2024
Gunderson Dettmer's GDHQ Wins Legal Breakthrough's “Team Collaboration Platform of the Year”
Gunderson Dettmer is the winner of the “Team Collaboration Platform of the Year” award for its GDHQ in the 5th annual LegalTech Breakthrough Awards program conducted by LegalTech Breakthrough
Firm News
|September 5, 2024
Gunderson Dettmer Generative AI Resources
Gunderson Dettmer fuels Generative AI education in venture capital. Explore diverse AI resources: articles, client insights, events, podcasts, and webinars – all enhancing your engagement with this dynamic field.
Firm News
|August 23, 2024
Gunderson Dettmer is recognized as the top venture capital law firm in Latin America by PitchBook Global League Tables in H1 2024
Blog Posts 1 result
Public Ventures
|March 6, 2024
Client Insight: SEC Adopts New SPAC Regulatory Regime
Extension of Traditional IPO Investor Protections to SPAC Transactions Will Significantly Increase Costs, Complexity and Potential Liability for Market Participants Throughout the SPAC Lifecycle
